These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5446419)

  • 1. Rate of crystal growth of sulfathiazole and methylprednisolone.
    Mehta SC; Bernardo PD; Higuchi WI; Simonelli AP
    J Pharm Sci; 1970 May; 59(5):638-44. PubMed ID: 5446419
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphism and drug availability. II. Dissolution rate behavior of the polymorphic forms of sulfathiazole and methylprednisolone.
    Higuchi WI; Bernardo PD; Mehta SC
    J Pharm Sci; 1967 Feb; 56(2):200-7. PubMed ID: 6025774
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone.
    Simonelli AP; Mehta SC; Higuchi WI
    J Pharm Sci; 1970 May; 59(5):633-8. PubMed ID: 5446418
    [No Abstract]   [Full Text] [Related]  

  • 4. Various species of sulfathiazole form I.
    Shenouda LS
    J Pharm Sci; 1970 Jun; 59(6):785-7. PubMed ID: 5423078
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural studies on molecular complexes. V. Crystal structures of sulfathiazole-sulfanilamide and sulfathiazole-theophylline complexes.
    Shefter E; Sackman P
    J Pharm Sci; 1971 Feb; 60(2):282-6. PubMed ID: 5572456
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDIES ON THE MOLECULAR COMPOUNDS OF ORGANIC MEDICINALS. I. DISSOLUTION BEHAVIOR OF THE MOLECULAR COMPOUNDS OF SULFANILAMIDE AND SULFATHIAZOLE.
    SEKIGUCHI K; ITO K
    Chem Pharm Bull (Tokyo); 1965 Apr; 13():405-13. PubMed ID: 14294833
    [No Abstract]   [Full Text] [Related]  

  • 7. Succinylsulfathiazole crystal forms. III: Crystal growth studies.
    Moustafa MA; Ebian AR; Khalil SA; Motawi MM
    J Pharm Sci; 1975 Sep; 64(9):1485-9. PubMed ID: 1185562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal polymorphism of pharmaceuticals: probing crystal nucleation at the molecular level.
    Guiry KP; Kelleher JM; Lawrence SE; McAuliffe MT; Moynihan HA; Ryan AL
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):550-5. PubMed ID: 18035822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heats of transition of methylprednisolone and sulfathiazole by a differential thermal analysis method.
    Guillory JK
    J Pharm Sci; 1967 Jan; 56(1):72-6. PubMed ID: 6030499
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.
    Simonelli AP; Mehta SC; Higuchi WI
    J Pharm Sci; 1976 Mar; 65(3):355-61. PubMed ID: 1263082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of dissolution rates of poorly water-soluble drugs by crystallization in aqueous surfactant solutions I: Sulfathiazole, prednisone, and chloramphenicol.
    Chiou WL; Chen SJ; Athanikar N
    J Pharm Sci; 1976 Nov; 65(11):1702-4. PubMed ID: 994008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorph farming of acetaminophen and sulfathiazole on a chip.
    Lee T; Hung ST; Kuo CS
    Pharm Res; 2006 Nov; 23(11):2542-55. PubMed ID: 16969701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the molecular compounds of organic medicinals. IV. Physico-pharmaceutical properties of the molecular compound of homosulfanilamide and sulfathiazole.
    Sekiguchi K; Owada E; Ito K
    Chem Pharm Bull (Tokyo); 1967 Jun; 15(6):873-8. PubMed ID: 6076798
    [No Abstract]   [Full Text] [Related]  

  • 14. Adsorption of nonionic surfactants on sulfathiazole and naphthalene and flocculation-deflocculation behavior of these suspensions.
    Otsuka A; Sunada H; Yonezawa Y
    J Pharm Sci; 1973 May; 62(5):751-4. PubMed ID: 4705680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfonamides. III. Sulfathiazole derivatives of pyrazole and pyrazolone-5].
    Wrzeciono U; Krzysztofik B; Sterkowicz E; Danielewicz E
    Acta Pol Pharm; 1975; 32(4):405-11. PubMed ID: 1163251
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of crystal form on tensile strength of compacts of pharmaceutical materials.
    Summers MP; Enever RP; Carless JE
    J Pharm Sci; 1977 Aug; 66(8):1172-5. PubMed ID: 894506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Face specific surface properties of pharmaceutical crystals.
    Muster TH; Prestidge CA
    J Pharm Sci; 2002 Jun; 91(6):1432-44. PubMed ID: 12115843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method.
    McGinity JW; Maincent P; Steinfink H
    J Pharm Sci; 1984 Oct; 73(10):1441-4. PubMed ID: 6502495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succinylsulfathiazole crystal forms. I. Preparation, characterization, and interconversion of different crystal forms.
    Moustafa MA; Khalil SA; Ebian AR; Motawi MM
    J Pharm Sci; 1974 Jul; 63(7):1103-9. PubMed ID: 4854519
    [No Abstract]   [Full Text] [Related]  

  • 20. Succinylsulfathiazole crystal forms. II: Effect of additives on kinetics of interconversion.
    Ebian AR; Moustafa MA; Khalil SA; Motawi MM
    J Pharm Sci; 1975 Sep; 64(9):1481-4. PubMed ID: 1185561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.